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ÖZET
Amaç: Dışkı örneklerinde antijen testinin, izoenzim ana-
lizi ile birlikte kültür kadar duyarlı ve özgül bir test olduğu 
ve endemik bölgelerde mikroskopik bakıyı safdışı bıraktı-
ğı gösterilmiştir. Bu çalışmanın amacı; dışkı örneklerinde 
direkt mikroskopik bakı ve ELISA yöntemi ile Entamoeba 
histolytica varlığının araştırılmasıdır.
Gereç ve yöntem: Çalışmaya; Eylül 2010-Mayıs 2011 
tarihleri arasında Kızıltepe Devlet Hastanesi Mikrobiyoloji 
laboratuvarına gönderilen, farklı yaş gruplarındaki hasta-
lara ait 975 dışkı örneği dahil edildi. Tüm dışkı örnekleri-
ne nativ-Lugol yöntemi ve E.histolytica-özgül antijen testi 
(Adhesin Ag, Entamoeba CELISA Path) uygulandı.
Bulgular: Direkt bakıda nativ-Lugol yöntemi ile incelenen 
975 dışkı örneğinin 21’inde (%2.2) Entamoeba histolytica/
dispar kist ve/veya trofozoitleri görüldü. Ayrıca 975 dışkı 
örneğinde, ELISA yöntemi ile E.histolytica özgül antijeni 
araştırıldı. Direk mikroskopik bakıda Entamoeba histolyti-
ca/dispar kist ve/veya trofozoitleri görülen hastaların sade-
ce 4’ünde E.histolytica özgül antijeninin varlığı tespit edildi. 
Fakat 3 hastanın direk mikroskopik bakısında Entamoeba 
histolytica/dispar  kist  ve/veya  trofozoitleri  görülmezken 
E.histolytica özgül antijeni ise pozitif bulundu. Toplam ola-
rak 7 (% 0.7) hastanın dışkı örneğinde E.histolytica özgül 
antijeninin varlığı tespit edildi. E.histolytica özgül antijeni 
saptanan olgulara uygun tedavi başlandı.
Sonuç: Hastaların gereksiz tedavi almasını önlemek için 
dışkı  örneklerinde  E.histolytica  özgül  antijeninin  varlığı 
araştırılmalıdır.
Anahtar kelimeler: Entamoeba histolytica/dispar, özgül 
antijen, ELISA, direk mikroskopik bakı
ABSTRACT
Objectives:  Stool  antigen  assay  has  been  shown  to 
be as sensitive and specific as culture with isoenzyme 
analysis and to outperform microscopy for the detection 
of E.histolytica in endemic area. The aim of the present 
study is to investigate the presence of E.histolytica by di-
rect microscopic examination and ELISA in stool samples, 
comparatively.
Materials and methods: Between September 2010 and 
May 2011, a total of 975 stool samples of patients in dif-
ferent age groups were sent to microbiology laboratory 
of Kızıltepe General Hospital. Native-Lugol method and 
E.histolytica-specific antigen test (Adhesin Ag, Entamoe-
ba CELISA Path) was applied to all stool samples.
Results:  E.histolytica/dispar  cysts  and/or  trophozoites 
were observed in 21 out of 975 (2.2%) stool samples ex-
amined by native-Lugol method. In addition, E.histolytica-
specific antigen in 975 stool specimens was investigated 
by ELISA. E.histolytica-specific antigen was determined 
in 4 patients which had E.histolytica/dispar cysts and/or 
trophozoites at direct microscopic examination. Although 
at  direct  microscopy  of  3  patients  E.histolytica/dispar 
cysts  and/or  trophozoites  not  observed,  E.histolytica-
specific antigen was found favorable. A total of 7 (0.7%) 
E.histolytica specific antigen was found in the patient’s 
stool samples. Patients with E.histolytica-specific antigen 
were treated.
Conclusion: E.histolytica specific antigen in stool sam-
ples should be investigated to avoid unnecessary treat-
ment.
Key words: Entamoeba histolytica/dispar, specific anti-
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INTRODUCTION
Entamoeba  histolytica  is  the  causative  agent  of 
amoebiasis  and  is  globally  considered  a  leading 
parasitic  cause  of  human  mortality.  Clinical  fea-
tures of amoebiasis due to E.histolytica range from 
asymptomatic  colonization  to  amebic  dysentery 
and  invasive  extraintestinal  amoebiasis,  which  is 
manifested  most  commonly  in  the  form  of  liver 
abscesses. Approximately 50 million people have 
invasive  disease,  resulting  in  100,000  deaths  per 
year.1 Although the parasite has a worldwide dis-
tribution, high prevalence rates of more than 10% 
of the population have been reported from various 
developing countries.2 Entamoeba dispar appears to 
be about 10 times more common than E.histolytica, 
with most of the 500 million people infected with 
E.histolytica/E.dispar carrying E.dispar.1
Entamoeba histolytica and Entamoeba dispar 
parasitize approximately 10% of the world popula-
tion, of which 90% are asymptomatic infections.3 
Infections of E.histolytica and E.dispar are often 
diagnosed by demonstrating cysts or trophozoites 
in a stool sample. A great number of methods for 
distinguishing  E.histolytica  from  E.dispar  have 
now been described in the literature.4 E.dispar and 
E.histolytica are morphologically indistinguishable 
from one another. Isoenzyme analysis is considered 
the “gold standard” for differentiating E.histolytica 
and E.dispar, but this method is not currently avail-
able and not readily usable for routine diagnosis. 
More recently, several studies have been devoted to 
the development of new techniques either based on 
monoclonal antibodies or molecular biology meth-
ods to successfully distinguish the two species in 
human feces.3 Stool antigen assay has been shown 
to be as sensitive and specific as culture with isoen-
zyme analysis and to outperform microscopy for the 
detection of E.histolytica in areas of endemicity.5
Reliable distinction would have a medical im-
pact as until now, both infections are usually treated, 
whereas only approximately 10% (pathogenic infec-
tions) need to be treated. This proportion drops too 
much lower levels in developed countries, where 
E.histolytica infection is not endemic and occurs 
mostly after travelling to areas of endemicity.3
The present study was carried out to examine 
the prevalence and etiological agent of amoebia-
sis in Kızıltepe. The main aim of this study was to 
demonstrate the importance of correctly identifying 
E.histolytica in order to avoid unnecessary treatment 
costs and delayed treatment of actual infection.
MATERIALS AND METHODS
Collection of stool samples
Between September 2010 and May 2011, a total of 
975 stool samples of patients of different age groups 
sent to Microbiology Laboratory of Kızıltepe Gen-
eral Hospital were included in present study.
Microscopic examination
Stool  samples  were  investigated  by  native-Lugol 
examination. Lugol’s iodine was added to the stool 
smear and covered with a cover slip. Stool smears 
with saline or iodine examined microscopically at 
low (10X) and high (40X) magnifications within 15 
minutes.
The  identification  of  E.histolytica/dispar  tro-
phozoites was made by the characteristic movement 
of the protozoan and the presence of phagocytized 
red blood cells. The identification of amebic cysts 
(E.histolytica/dispar)  was  based  on  morphologic 
characteristics, (10-15 μm, spherical form, mature 
tetranucleated cysts having a central endosome).
Entamoeba antigen test
Following  microscopic  examination  by  native-
Lugol method, all of stool specimens were investi-
gated for Entamoeba histolytica/dispar screening by 
Micro-ELISA method using commercial kits (Ad-
hesin Ag, Entamoeba CELISA Path) regarding with 
the existence of adhesin antigens.
RESULTS
E.histolytica/dispar cysts and/or trophozoites were 
observed  in  21  out  of  975  (2.2%)  stool  samples 
examined  by  native-Lugol  method.  E.histolytica-
specific antigen in 975 stool specimens was investi-
gated by ELISA. E.histolytica-specific antigen was 
determined in 4 patients which had E.histolytica/
dispar cysts and/or trophozoites at direct microscop-
ic examination. Although at direct microscopy of 3 
patients E.histolytica/dispar cysts and/or trophozo-
ites not observed, E.histolytica-specific antigen was 
found favourable. A total of 7 (0.7%) E.histolytica 
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samples. Patients with E.histolytica-specific antigen 
had been treated.
DISCUSSION
Amoebiasis is defined as infection with Entamoeba 
histolytica, regardless of associated symptomatolo-
gy. In resource-rich nations, this parasitic protozoan 
is seen primarily in travelers to and emigrants from 
endemic areas. Infections range from asymptomatic 
colonization to amebic colitis and life-threatening 
abscesses. Importantly, disease may occur months 
to years after exposure. Although E.histolytica was 
previously thought to infect 10% of the world’s pop-
ulation, 2 morphologically identical but genetically 
distinct and apparently non-pathogenic Entamoeba 
species are now recognized as causing most asymp-
tomatic cases. To avoid unnecessary and possibly 
harmful therapies, clinicians should follow the diag-
nostic and treatment guidelines of the World Health 
Organization.6
Entameoba histolytica, 1 of the 2 Entamoeba 
species  with  similar  morphology  that  infect  hu-
mans,  causes  invasive  intestinal  and  extraintesti-
nal diseases, whereas Entamoeba dispar is found 
commensally and is non-invasive. Because of their 
morphologic similarity, E.histolytica and E.dispar 
cannot be differentiated microscopically. The anti-
gens of E.histolytica and E.dispar, however, may 
be detected by the ELISA method. Previous studies 
have found that the detection of antigens in the stool 
samples is as sensitive and specific as cultures and 
isoenzyme analyses.7
Studies  were  carried  out  at  a  mexican  pedi-
atric  hospital  to  determine  the  ratio  between  the 
pathogenic  species  Entamoeba  histolytica  and 
non-pathogenic species E.dispar using an enzyme 
linked  immunosorbent  assay  (ELISA)  to  detect 
the lectin (1 galactose N-acetyl D-galactosamine) 
of E.histolytica in feces. A close correlation was 
noted  between  the  presence  of  the  E.histolytica 
lectin and clinical symptoms. In this study, amoe-
bas were detected by microscopy in 120 children 
(either  E.histolytica  or  E.dispar).  But  while  al-
most all (13/14) of the children with E.histolytica 
had clinical symptoms, dysentery-feces with mo-
cus and blood, diarrhea, cramping abdominal pain, 
tenesmus rectal, flatulence, vomiting and headache, 
almost none (1/106) of the children infected with 
the non-pathogenic amoeba E.dispar had signs and 
symptoms. This suggests that much of the amoebia-
sis diagnoses made in Mexico are, in fact, due to 
non-pathogenic E.dispar.8
Malatyalı et al.9 reported that a total of 1449 
stool samples were examined by native-Lugol and 
Trichrome staining, and 312 (22%) samples were 
positive  for  one  or  more  parasite  species. Addi-
tionally,  22  (1.5%)  stool  samples  were  found  to 
be positive for the presence of E.histolytica/dispar 
cysts, and these samples were further examined by 
E.histolytica specific antigen based ELISA. As a re-
sult, ELISA test gave negative reactions for all the 
samples. Also, there was no cross reaction with other 
luminal protozoa such as Escherichia coli, Giardia 
intestinalis,  Blastocystis  hominis  and  Iodamoeba 
butschlii. The data reveals that E.histolytica preva-
lence may be lower than estimated.
A  record  is  available  that  indicates  that 
E.histolytica  is  more  common  than  E.dispar  in 
Zonguldak. Mengeloglu et al.10 reported that ame-
bic cysts were observed in 44 (0.37%) out of a total 
of 1720 stool specimens which were examined by 
direct microscopy. Entamoeba histolytica specific 
antigen was investigated with ELISA in the speci-
mens that cysts were observed. Specific antigen was 
detected in 26 (59.1%) of these specimens. Because 
of the low sensitivity of direct microscopy in con-
firming the prediagnosis of amoebiasis, it is neces-
sary to perform ELISA on the specimens in order to 
determine whether the patient should be treated or 
to prevent patients from being given an unnecessary 
treatment.
Zeyrek et al.11 reported that a total of 87 stool 
specimens  that  were  doubtful  using  the  native-
Lugol method were examined by the E.histolytica 
specific sensu-lato antigen based ELISA test and 
the Trichrome staining method. Of these 87 stool 
specimens,  23  (26.4%)  specimens  were  positive 
for E.histolytica/E.dispar trophozoites/cysts micro-
scopically using Trichrome staining and 19 (21.7%) 
of the stool specimens were found to be positive for 
the E.histolytica/E.dispar complex by the ELISA 
test.
Tuncay et al.12 reported that stool samples of 
9378 patients from different clinics, with several 
gastrointestinal  complaints  from  January  2004  to 
May 2006, were examined. All stool samples were 
examined  with  the  native-Lugol  method  and,  in 
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in Robinson’s medium and/or antigen detection in 
stool with the Entamoeba CELISA Path kit. Forty-
one cases (0.44%), in which Entamoeba histolytica/
Entamoeba dispar cysts and/or trophozoites were 
detected by at least one method, were found to be 
positive.
In the world, the prevalence of E.histolytica is 
around 10% on average, but reaches up to 50% or 
80% have been reported, in some regions. In Turkey 
the prevalence of E.histolytica is reported 0 to 17%. 
However, there are studies reporting high rates of 
detected between 43.2 to 77.7%.10
In the light of earlier reports about the preva-
lence of amoebiasis in such subjects, interpretation 
is very difficult because older data did not differenti-
ate between morphologically identical species, one 
that is non-invasive (E.dispar) and are that is inva-
sive (E.histolytica), but they have a high degree of 
divergence. It is very important to keep in mind that 
according to the older data, many E.histolytica in-
fections were most probably confused with E.dispar 
due to limited data obtained from microscopic ex-
aminations.13
In conclusion, our findings are consistent with 
those previously reported studies in Turkey. Direct 
microscopic diagnosis of amoebiasis is not an effi-
cient method for the diagnosis of E.histolytica, so we 
recommend stool antigen detection tests today offer 
a practical, sensitive, and specific method for the 
clinical laboratory to detect intestinal E.histolytica.
REFERENCES
1. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness 
J. Laboratory diagnostic techniques for Entamoeba species. 
Clin Microbiol Rev 2007;20(3):511-32.
2. Stanley SL. Amoebiasis. Lancet 2003;361:1025-34.
3. Gonin P, Trudel L. Detection and differentiation of Entam-
oeba histolytica and Entamoeba dispar isolates in clinical 
samples by PCR and enzyme-linked immunosorbent assay. 
J Clin Microbiol 2003;41(1):237-41.
4. Nesbitt RA, Mosha FW, Katki HA, Ashraf M, Assenga C, 
Lee  CM.  Amebiasis  and  comparison  of  microscopy  to 
ELISA technique in detection of Entamoeba histolytica and 
Entamoeba dispar. J Natl Med Assoc 2004;96(5):671-7.
5.  Pillai  DR,  Keystone  JS,  Sheppard  DC,  MacLean  JD, 
MacPherson DW, Kain KC. Entamoeba histolytica and En-
tamoeba dispar: epidemiology and comparison of diagnos-
tic methods in a setting of nonendemicity. Clin Infect Dis 
1999;29(5):1315-8.
6. Pritt BS, Clark CG. Amebiasis. Mayo Clinic Proceedings 
2008;83(10):1154-60.
7. Delialioglu N, Aslan G, Ozturk C, Ozturhan H, Sen S, Eme-
kdas G. Detection of Entamoeba histolytica antigen in stool 
samples in Mersin, Turkey. J Parasitol 2008;94(2):530-2.
8. Redondo RB, Martinez Mendez LG, Baer G. Entamoeba 
histolytica and Entamoeba dispar: differentiation by En-
zyme-Linked Immunosorbet Assay (ELISA) and its clini-
cal  correlation  in  pediatrics  patients.  Parasitol  Latinoam 
2006;61:37-42.
9. Malatyalı E, Özçelik S, Çeliksöz A. The investigation of En-
tamoeba histolytica Prevalance in some villages of Sivas by 
ELISA method. Turkiye Parazitol Derg 2011;35:6-9.
10. Mengeloglu FZ, Aktas E, Kulah C, Comert Begendik F. De-
tection of Entamoeba histolytica in stool specimens with the 
ELISA Method. Türkiye Parazitol Derg 2009;33(1):1-3.
11. Yildiz Zeyrek F, Ozbilge H, Yüksel MF, Zeyrek CD, Sir-
matel F. Parasitic fauna and the frequency of Entamoeba 
histolytica/Entamoeba dispar detected by ELISA in stool 
samples  in  Sanliurfa,  Turkey.  Türkiye  Parazitol  Derg 
2006;30(2):95-8.
12. Tuncay S, Inceboz T, Over L, et al. The evaluation of the 
techniques used for diagnosis of Entamoeba histolytica in 
stool specimens. Turkiye Parazitol Derg 2007;31(3):188-
93.
13. Tanyuksel M, Petri WA. Laboratory Diagnosis of Amoebia-
sis. Clin Microbiol Rev 2003;16(4):713-29.